Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The study is designed to assess the efficacy of treatment with divalproex sodium (DS) vs.
placebo in childhood/adolescent autism fulfilling DSM-IV and Autism Diagnostic Interview
(ADI) criteria. Currently, there are no FDA-approved treatments for this disorder, although
behavioral and educational therapies and a variety of medications may play a role in the
management of some autistic symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Montefiore Medical Center
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)